News|Articles|December 8, 2025
Low-pg/mL quantification of TL 13-112, a proteolysistargeting chimera (PROTAC) in rat plasma
Author(s)SCIEX
This technical note demonstrates a highly sensitive, robust and rapid workflow to quantify TL 13-112, a selective ALK degrader, and its inactive control, TL 13-110, in rat plasma using a high-end triple quadrupole mass spectrometer.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Next-Generation Modalities Drive New Antibody Discovery
2
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
3
European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE
4
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
5